|
Market Closed -
Australian S.E.
08:55:19 09/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.003500 AUD | +16.67% |
|
-12.50% | -89.71% |
| 10-30 | ImpediMed Limited, Q1 2027 Earnings Call, Oct 30, 2026 | |
| 10-27 | Impedimed Announces Appointment of Nicole L. Stout as Chief Clinical Innovation Officer | CI |
Chart: Technical Analysis
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| IPD | Delayed | |
OTC Markets
| IPDQF | Delayed | |
|
Deutsche Boerse AG
| R1J | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.0045 | 0.005 | 0.0107 |
| Spread/Res. | -22.22% | -30.00% | -67.29% |
| Spread/Supp. | +40.00% | +40.00% | +118.75% |
| Support | 0.0025 | 0.0025 | 0.0016 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- IPD Stock
- Charts ImpediMed Limited
Select your edition
All financial news and data tailored to specific country editions
